Pharmacist administered vaccinations

In accordance with the Australian Immunisation Handbook.

May be administered in combination e g., ADT, dTpa, DTPa

May be administered in combination with other antigens

May be administered in combination with other antigens

Shingrix vaccine brand only

Mandatory completion of the additional training module: Japanese encephalitis – A learning resource for immunisation providers hosted by the Pharmaceutical Society of Australia or the Pharmacy Guild of Australia

May be administered in combination with other antigens

MenACWY (quadrivalent) conjugate vaccine

MenC – monovalent meningococcal serogroup C – tetanus toxoid conjugate

May be administered in combination e g., ADT, dTpa, DTPa

Pneumococcal conjugate vaccine only

Aboriginal and Torres Strait Islander people aged 50 years and over and non-Aboriginal people aged 70 years and over

May be administered in combination with other antigens

60 years and over
Arexvy and Abrysvo only
In accordance with Therapeutic Goods Administration (TGA) approved product information and Australian Technical Advisory Group on Immunisation ( ATAGI) recommendations

May be administered in combination e g., ADT, dTpa, DTPa

Intramuscular injection (IMI) formulation only

May be administered in combination with other antigens

May be administered in combination with other antigens

Authority to vaccinate

NSW Pharmacist Vaccination Standards

Funding considerations and ordering government-funded vaccines

1.    Covid vaccination funding is available see: COVID-19 Vaccination in Community Pharmacy (CVCP) Program.

2.    Community pharmacies may be eligible to receive a payment for administering National Immunisation Program (NIP) Vaccines. For information about this program, see National Immunisation Program Vaccinations in Pharmacy (NIPVIP) Program.

3.    Community pharmacies may be able to order free stock of NIP vaccines. Refer to Guidance for Pharmacist Immunisers – Access to pharmacist approved NIP vaccines for information about ordering vaccines.

4.    State funded Hepatitis A vaccines are available for NSW residents for post exposure management.

5.    State funded Hepatitis B vaccines are available for some NSW residents including:

• Aboriginal people
• household and sexual contacts of acute and chronic hepatitis B cases
• men who have sex with men
• injecting drug users
• sex workers

6.    State funded MMR vaccines are available for NSW residents born during or after 1966 and rubella seronegative post-natal women.

7.    State funded Japanese encephalitis vaccines are available for NSW residents who meet the specified criteria.

Diphtheria-tetanus-acellular pertussis combination vaccine only

Measles-mumps-rubella (MMR) combination vaccine only

diphtheria-tetanus-acellular pertussis combination vaccine only

Diphtheria-tetanus-acellular pertussis combination vaccine only

Authority to vaccinate 

Pharmacist Vaccination Scheduled Substance Treatment Protocol

MPox SSTP

JE SSTP

Funding considerations and ordering government-funded vaccines

1. Covid vaccination funding is available see: COVID-19 Vaccination in Community Pharmacy (CVCP) Program.

2. Community pharmacies may be eligible to receive a payment for administering National Immunisation Program (NIP) Vaccines. For information about this program, see National Immunisation Program Vaccinations in Pharmacy (NIPVIP) Program.

3. Community pharmacies are able to order free stock of NIP vaccines. Contact NT CDC for more information at TEHS@nt.gov.au.

4. Some NT residents may be eligible for a free Japanese Encephalitis vaccine. Information about this program is available here.

Last reviewed: 06/08/2024 

Authority to vaccinate

Extended practice authority ‘Pharmacists’

Funding considerations and ordering government-funded vaccines

1.       Covid vaccination funding is available see: COVID-19 Vaccination in Community Pharmacy (CVCP) Program.

2.       Community pharmacies may be eligible to receive a payment for administering National Immunisation Program (NIP) Vaccines. For information about this program, see National Immunisation Program Vaccinations in Pharmacy (NIPVIP) Program.

3.       Community pharmacies may be able to order free stock of NIP vaccines. For information about ordering NIP vaccines see QLD Health Immunisation website.

4.       Meningococcal B State funded program to commence in early 2024 – details TBC.

5.       Queensland residents may be eligible for a free influenza vaccine. For information about this program see QLD Health 2024 Free Flu Vaccination Program.

Must complete additional training*

Authority to vaccinate

The Controlled Substances (Poisons) Regulation 2011, sub regulation 18(3) provides authorisation for a registered health practitioner determined by the Minister, to administer vaccine without a medical order. The authorisation is conditional to the administration being in accordance with the Vaccine Administration Code (last updated December 2023).

Funding considerations and ordering government-funded vaccines

1.    Covid vaccination funding is available see: COVID-19 Vaccination in Community Pharmacy (CVCP) Program.

2.    Community pharmacies may be eligible to receive a payment for administering National Immunisation Program (NIP) Vaccines. For information about this program, see National Immunisation Program Vaccinations in Pharmacy (NIPVIP) Program.

3.    Community pharmacies may be able to order free stock of NIP vaccines. For information about ordering NIP vaccines, see SA Health Immunisation website.

4.    State funded Japanese Encephalitis vaccines are available for SA residents who meet the specified criteria.

For 5 to 10 years and over old: pharmacist must have additional paediatric authorisation with the Tasmanian Dept of Health

diphtheria-tetanus-acellular pertussis (dTpa) combination vaccine only

Vaccination for those recommended, but not funded, to receive Hepatitis A vaccination unrelated to travel

Excludes vaccination for travel (including to endemic regions) and vaccination for post-exposure prophylaxis

Shingrix® only

Catch-up vaccination limited to persons requiring a single dose only

For 5 to 10 years and over old: pharmacist must have additional paediatric authorisation with the Tasmanian Dept of Health

Mumps

Rubella

Vaccination for catch-up funded under the NIP, including combination products (e.g., measles , mumps, rubella and varicella)

Vaccination of individuals funded under the NIP and people recommended (not funded) for MenACWY vaccination

Vaccination for those recommended to receive a Meningococcal B vaccination unrelated to travel, not funded under the NIP

diphtheria-tetanus-acellular pertussis (dTpa) combination vaccine only

Refer to the Pneumococcal Vaccination Schedule decision tree when considering vaccination

Including in combination products with other antigens

People aged 60 years and over (AREXVY® and ABRYSVO®)

Pregnant women 18 years of age and over (ABRYSVO® ONLY), recommended at 28-36 weeks gestation.

diphtheria-tetanus-acellular pertussis (dTpa) combination vaccine only

Excludes vaccination for tetanus prophylaxis related to wound management

Including in combination products with other antigens

Authority to vaccinate

Tasmanian Immunisation Program Guidelines

Funding considerations and ordering government-funded vaccines

1.    Covid vaccination funding is available see: COVID-19 Vaccination in Community Pharmacy (CVCP) Program.

2.    Community pharmacies may be eligible to receive a payment for administering National Immunisation Program (NIP) Vaccines. For information about this program, see National Immunisation Program Vaccinations in Pharmacy (NIPVIP) Program.

3.    Community pharmacies may be able to order free stock of NIP vaccines. Refer to Tasmanian Department of Health – Immunisation Providers for information about ordering vaccines.

4.    State funded Hepatitis B vaccines are available for people who are at increased risk of acquiring hepatitis B virus.

5.    State funded MMR vaccines are available for unvaccinated (no evidence of vaccination) or seronegative people born during or after 1966 (based on serology).

Excludes vaccination of people that are contacts in the event of a case of diphtheria, unless directed by the Victorian Department of Health

Excludes vaccination with diphtheria antitoxin

Excludes travel purposes unless pharmacist/pharmacy is participating in the Victorian Community Pharmacist Statewide Pilot

Excludes vaccination of contacts in the case of hepatitis A, unless directed by the Victorian Department of Health

Excludes vaccination of people following acute exposure to potentially infected blood or body fluids
Excludes immunisation with immunoglobulin

Only under the Victorian Community Pharmacist Statewide Pilot

Excludes vaccination of people following acute exposure to potentially infected blood or body fluids

Excludes immunisation with immunoglobulin

Only under the Victorian Community Pharmacist Statewide Pilot

Excludes immunisation with immunoglobulin

Excludes travel purposes unless pharmacist/pharmacy is participating in the Victorian Community Pharmacist Statewide Pilot

Excludes travel purposes unless pharmacist/pharmacy is participating in the Victorian Community Pharmacist Statewide Pilot

Excludes travel purposes unless pharmacist/pharmacy is participating in the Victorian Community Pharmacist Statewide Pilot

Excludes travel purposes

Mandatory completion of the additional training module: Japanese
encephalitis eLearning module 

Only for people recommended for vaccination as listed on the Victorian Department of Health’s Japanese encephalitis in Victoria website

Excludes vaccination of contacts in the event of a case of measles, mumps, rubella unless directed by the Victorian Department of Health

Excludes immunisation with immunoglobulin

Excludes travel purposes unless pharmacist/pharmacy is participating in the Victorian Community Pharmacist Statewide Pilot

Excludes vaccination of contacts in the event of a case of meningococcal disease unless directed by the Victorian Department of Health

Excludes travel purposes unless pharmacist/pharmacy is participating in the Victorian Community Pharmacist Statewide Pilot

Mandatory completion of the additional training module: Monkeypox
vaccination eLearning module 

Excludes vaccination for travel purposes other than those people recommended for vaccination as listed on the Department of Health’s Monkeypox webpage

Excludes vaccination of people that are contacts in the event of a case of pertussis, unless directed by the Victorian Department of Health

Excludes travel purposes unless pharmacist/pharmacy is participating in the Victorian Community Pharmacist Statewide Pilot

Excludes travel purposes unless pharmacist/pharmacy is participating in the Victorian Community Pharmacist Statewide Pilot

Only under the Victorian Community Pharmacist Statewide Pilot

Excludes travel purposes other than those people recommended for immunisation as listed on the Department of Health’s Respiratory syncytial virus (RSV) immunisation webpage.

Excludes travel purposes unless pharmacist/pharmacy is participating in the Victorian Community Pharmacist Statewide Pilot

Excludes vaccination for the express purpose of post-exposure prophylaxis in people with a tetanus-prone wound

Excludes travel purposes unless pharmacist/pharmacy is participating in the Victorian Community Pharmacist Statewide Pilot

Only under the Victorian Community Pharmacist Statewide Pilot

Authority to vaccinate

Medicines and poisons – Secretary approval S148 27 March 2024

Medicines and poisons – Secretary approval (Pilot) S528 5 October 2023

Medicines and poisons – Secretary approval (COVID-19) S530 5 October 2023

Medicines and poisons – Secretary approval (Intern Pharmacist Immunisers) S194-24 24 April 2024

Funding considerations and ordering government-funded vaccines

1.    Covid vaccination funding is available see: COVID-19 Vaccination in Community Pharmacy (CVCP) Program.

2.    Community pharmacies may be eligible to receive a payment for administering National Immunisation Program (NIP) Vaccines. For information about this program, see National Immunisation Program Vaccinations in Pharmacy (NIPVIP) Program.

3.    Community pharmacies may be able to order free stock of NIP vaccines. Refer to Ordering vaccines for information.

4.    State funded Hepatitis B vaccines are available for people at risk of hepatitis B infection.

5.    State funded MMR vaccines are available for all adults born during or since 1966 and aged from 20 years and over without evidence of two documented doses of valid MMR vaccine or without serological evidence of immunity.

6.    State funded vaccines for Japanese encephalitis are available for some Victorian residents.

7.    State funded vaccines for mpox (monkeypox) are available for some Victorian residents.

Authority to vaccinate

Pharmacists – Administration of vaccines by pharmacists

Pharmacists – COVID-19 vaccination

Pharmacists (WA Health) – COVID-19 vaccination 

Funding considerations and ordering government-funded vaccines

1. Covid vaccination funding is available: COVID-19 Vaccination in Community Pharmacy (CVCP) Program.

2. Community pharmacies may be eligible to receive a payment for administering National Immunisation Program (NIP) Vaccines. For information about this program, see National Immunisation Program Vaccinations in Pharmacy (NIPVIP) Program.

3. Community pharmacies are able to order free stock of NIP vaccines. Refer to Immunisation provider information and resources for information about ordering vaccines.